UNFPA procures medicines that have been selected from the WHO Model List of Essential Medicines as well as National Essential Drugs Lists. In consultation with WHO and other UN agencies, UNFPA has developed a Quality Assurance Policy for Reproductive Health Medicines. The suppliers of medicines procured by UNFPA must have a current Good Manufacturing Practice certification issued by an authority part of the Pharmaceutical Inspection Co-operation Scheme, PIC/s, manufacturing licenses, national regulatory approval, and be qualified for procurement through the evaluation processes outlined in the Policy.